Skip to main content

Table 3 Impact of KITL541, tumor size, location, mitotic index and mutational status on RFS at 5 years in multivariate analysis

From: KIT exon 10 variant (c.1621 A > C) single nucleotide polymorphism as predictor of GIST patient outcome

Variable HR (95 % CI) P
KIT L541 6.1 (1.8–21) 0.004
Tumor size (<50 mm versus ≥ 50 mm) 3.6 (1.1–12) 0.03
Location (gastric versus non gastric) 0.5 (0.1–2) 0.06
Mitotic index per 50 HPF (<5 versus ≥5) 6.2 (1.7–23) 0.006
Mutation status (all other versus KIT exon 11) 1.5 (0.4–5) 0.6
  1. HR Hazard ratio, CI confidence intervals